PAP treatment can reduce UACR in patients with MS and OSAHS, and has the effect of improving metabolic disorders. The decrease of UACR in patients may be related to the decrease of visceral fat and the improvement of insulin resistance.
Keyphrases
- insulin resistance
- end stage renal disease
- mass spectrometry
- adipose tissue
- multiple sclerosis
- ms ms
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- metabolic syndrome
- high fat diet
- prognostic factors
- peritoneal dialysis
- polycystic ovary syndrome
- patient reported
- drug induced
- glycemic control
- smoking cessation